GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Carasent AB (publ) CARA.ST · SEK

N/A · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

25.60

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Carasent AB (publ)

Its shares trade on Nasdaq Stockholm under the ticker CARA.ST. It has been listed since 9 December 2024. In the fiscal year to 31 December 2025, it reported revenue of SEK 343.8m and net income of SEK 34.7m. At that date it held total assets of SEK 941.0m and shareholders' equity of SEK 808.0m.

Carasent AB (publ) is a SE-based company operating in industry. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2024-12-09. Carasent AB (publ) is a Sweden-based technology company specializing in developing mission-critical software for the health and care sector. The firm's product portfolio includes electronic health record systems (EHR), advanced business intelligence tools, and a range of ecosystem services designed to enhance the efficiency and healthcare operations. Its mission is to develop solutions that allow providers to deliver better care, streamline their operations, and ultimately improve patient outcomes. Carasent is headquartered in Gothenburg.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
9 Dec 2024

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Carasent AB (publ) specializes in mission-critical health care software solutions for Sweden.
  • The company's electronic health record systems (EHR) are designed to improve patient outcomes and streamline operations.
  • Carasent's business intelligence tools enhance efficiency within the Swedish health care sector.

Weaknesses

  • Carasent AB (publ) operates solely in the Swedish market without international expansion.
  • The company's focus on health care limits diversification across other industries.
  • Carasent's product portfolio lacks integration with global health care standards.

Opportunities

  • Carasent AB (publ) can expand its EHR systems to other Nordic countries like Norway and Denmark.
  • The growing demand for digital health solutions in Sweden presents significant market potential.
  • Carasent's business intelligence tools could be adapted for broader European health care applications.

Threats

  • Carasent AB (publ) faces competition from established health care software providers in Sweden.
  • Regulatory changes in the Swedish health care sector could impact product compliance.
  • Economic downturns in Sweden may reduce public sector spending on health care technology.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.